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GluA1, GluA2, GluA3, and GluA4 are the constitutive subunits of amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid receptors (AMPARs), the major mediators of fast excitatory trans-
mission in the mammalian central nervous system. Most AMPARs are Ca2+-impermeable
because of the presence of the GluA2 subunit. GluA2 mRNA undergoes an editing process
that results in a Q–R substitution, a key factor in the regulation of AMPAR Ca2+-permeability.
AMPARs lacking GluA2 or containing the unedited subunit are permeable to Ca2+ and Zn2+.
The phenomenon physiologically modulates synaptic plasticity while, in pathologic condi-
tions, leads to increased vulnerability to excitotoxic neuronal death. Given the importance
of these subunits, we have therefore evaluated possible associations between changes
in expression levels of AMPAR subunits and development of cognitive deficits in 3xTg-AD
mice, a widely investigated transgenic mouse model of Alzheimer’s disease (AD). With
quantitative real-time PCR analysis, we assayed hippocampal mRNA expression levels of
GluA1–4 subunits occurring in young [3 months of age (m.o.a.)] and old (12 m.o.a) Tg-AD
mice and made comparisons with levels found in age-matched wild type (WT) mice. Effi-
ciency of GluA2 RNA editing was also analyzed. All animals were cognitively tested for
learning short- and long-term spatial memory with the Morris Water Maze (MWM) navi-
gation task. 3xTg-AD mice showed age-dependent decreases of mRNA levels for all the
AMPAR subunits, with the exception of GluA2. Editing remained fully efficient with aging
in 3xTg-AD and WT mice. A one-to-one correlation analysis between MWM performances
and GluA1–4 mRNA expression profiles showed negative correlations between GluA2 lev-
els and MWM performances in young 3xTg-AD mice. On the contrary, positive correlations
between GluA2 mRNA and MWM performances were found in young WT mice. Our data
suggest that increases of AMPARs that contain GluA1, GluA3, and GluA4 subunits may
help in maintaining cognition in pre-symptomatic 3xTg-AD mice.
Keywords:AMPA receptors, GluA1–4, gene expression, RNA editing, neurotransmission, 3xTg-AD mice, hippocam-
pus, cognitive deficits
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative dis-
order leading to the most common form of dementia. Amyloid-
and tau-dependent pathology (Goedert and Spillantini, 2006) are
the main features of the disease, but impairment of glutamatergic
transmission and excitotoxicity also play an important role in the
pathogenic cascade that leads to synaptic dysfunction, neuronal
loss, and brain atrophy (Small et al., 2001; Selkoe, 2002).
The glutamate receptor family encompasses three types of
ionotropic receptors, NMDAR, amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPAR), and some kainate
receptors as well as metabotropic receptors (mGluRs I–III)
(Traynelis et al., 2010). In the mammalian central nervous sys-
tem, glutamatergic receptors selectively activated by the α-AMPA
mediate the majority of fast excitatory synaptic transmission (Bliss
and Collingridge, 1993). AMPARs are composed of four differ-
ent subunits: GluA1, GluA2, GluA3, and GluA4. AMPAR subunits
are organized in homo- or heterotetrameric complexes (Borges
and Dingledine, 1998). The ordered combination of AMPAR sub-
units leads to the formation of distinct receptors that can differ
upon functional features like ion selectivity or inward rectifica-
tion as well as capability to assemble in functional complexes
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containing scaffolding proteins and signaling molecules. AMPAR
subunits, although similar in structure, show distinct variations
in their C-terminal domains, a property that results due to the
presence of selective sites that are targets for phosphorylation
or protein–protein interactions (Shepherd and Huganir, 2007).
Post-transcriptional modifications of GluA1–4 pre-mRNAs, like
RNA editing or alternative splicing, further modulate AMPAR
functioning.
The GluA2 subunit represents a major functional switch for
the receptor as its presence confers impermeability to important
divalent cations like Ca2+ and Zn2+. The GluA2 subunit under-
goes a post-transcriptional editing process at the Q/R site that
promotes a glutamine to arginine substitution in the channel-
forming intramembrane segment. The presence of the arginine
residue in the pore of the channel inhibits the permeability to
divalents (Hollmann et al., 1991; Hume et al., 1991; Sommer
et al., 1991; Lomeli et al., 1994; Rosenthal and Seeburg, 2012).
Most AMPARs contain the GluA2 subunit and are therefore Ca2+-
impermeable (CaI-AMPARs). However, significant expression of
Ca2+-permeable AMPARs (CaP-AMPARs) occurs in several brain
regions and in subsets (like hippocampal GABAergic interneurons
or glutamatergic hippocampal pyramidal neurons) of neuronal
populations, a process that is also dependent upon develop-
ment (Jonas et al., 1994; Geiger et al., 1995; Ogoshi and Weiss,
2003; Cull-Candy et al., 2006). Interestingly, the AMPAR sub-
unit composition and resulting Ca2+-permeability of the channels
are not static processes. AMPARs undergo a constant and “on
demand” dynamic remodeling that is largely driven by varia-
tions in neuronal activity or changed in response to pathologi-
cal conditions (Liu and Cull-Candy, 2000, 2002; Liu and Zukin,
2007).
Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tors play a central role in the modulation of synaptic plasticity.
A strong body of evidence has shown that regulation of AMPAR
trafficking at membranes and variations in receptor functioning
are critically involved in many forms of synaptic plasticity (Liu and
Cull-Candy, 2002; Huganir and Nicoll, 2013). For instance, synap-
tic recruitment of AMPARs is required for the development of
long-term potentiation (LTP), whereas a decrease in number and
function of these receptors affects long-term depression (LTD)
(Carroll et al., 1999; Song and Huganir, 2002; Bredt and Nicoll,
2003). The switch between CaI- and CaP-AMPARs is occurring
at different stages of synaptic plasticity. CaP-AMPARs are tran-
siently incorporated during early stages of NMDAR-dependent
LTP in CA1 hippocampal pyramidal neurons and replaced with
CaI-AMPARs for plasticity maintenance (Plant et al., 2006). CaP-
AMPARs also play a key role in NMDAR-independent plasticity
mechanisms like synaptic scaling, an homeostatic form of plastic-
ity by which neurons restore and adjust baseline levels of activity
via a slow modification in glutamatergic receptor trafficking at
synaptic sites (Pérez-Otaño and Ehlers, 2005; Hou et al., 2008;
Huganir and Nicoll, 2013).
Glutamate receptors are crucial for synaptic plasticity, but also
possess a dark side as large influx of divalents like Ca2+ and Zn2+
through sustained activation of NMDARs and CaP-AMPARs is
considered a major trigger for the initiation of the excitotoxic
cascade that leads to neuronal death in a number of acute brain
disorders like ischemia, brain trauma, and seizures as well as in
neurodegenerative disease like amyotrophic lateral sclerosis (ALS)
and AD (Lee et al., 1999; Weiss and Sensi, 2000; Weiss, 2011). In
particular, overactivation of CaP-AMPARs leads to Ca2+ and Zn2+
overloads in the neuronal cytosol and in mitochondria where the
two cations synergistically act to promote generation of reactive
oxygen species (ROS), necrosis as well as release of pro-apoptotic
mediators (Weiss and Sensi, 2000; Sensi et al., 2009). Thus, alter-
ations in levels of GluA2 and/or CaP-AMPARs mRNA expression
levels or changes in AMPAR trafficking at the post-synaptic mem-
brane can greatly influence synaptic efficacy as well as neuronal
survival (Weiss and Sensi, 2000; Cull-Candy et al., 2006; Liu and
Zukin, 2007; Weiss, 2011). Deregulation in GluA2 mRNA editing
at the Q/R site, a process usually extremely efficient (near 100%),
has been associated with important neurotoxic consequences and
shown to occur in transient global ischemia or several neurodegen-
erative conditions (Pellegrini-Giampietro et al., 1997; Kawahara
et al., 2004; Peng et al., 2006).
Whereas the involvement of AMPARs has been widely estab-
lished in several neurological disorders (Weiss, 2011), the role
of these receptors in AD remains elusive. Furthermore, largely
unknown is what CaP-AMPARs do in the AD brain, a major
knowledge gap given the important deregulation of divalent
cations that occurs in the disease (Corona et al., 2011).
To investigate this issue in a preclinical AD model, we employed
a triple transgenic mouse model of AD, the 3xTg-AD. These Tg
mice, by harboring three human dementia-related transgenes,
APPswe, PS1M146V, and tauP301L, reproduce key AD-related fea-
tures like amyloid beta- (Aβ) and tau-dependent pathology, as
well as an age-dependent development of synaptic dysfunction
and LTP deficits (Oddo et al., 2003). The model also shows an
important acceleration of expression changes of genes that are
related to aging, the other major contributing factor in the dis-
ease (Gatta et al., 2014). Both Aβ and tau pathologies occur in an
age- and region-dependent manner,another feature that resembles
what found in the AD brain (Mesulam, 2000) where Aβ plaques
are known to precede neurofibrillary tangles (NFTs) formation
(Mastrangelo and Bowers, 2008).
Thus, the aim of our study was to evaluate age-dependent
changes in AMPAR gene transcriptional levels as well as GluA2
editing in a strategic region, the 3xTg-AD hippocampus.
Age-dependent modifications in GluA expression as well as
GluA2 editing were studied in young (3 months of age; m.o.a.)
and old (12 m.o.a) 3xTg-AD mice. Expression changes were com-
pared to age-dependent modifications occurring in age-matched
wild type (WT) mice. In the second part of the study, corre-
lations between GluA expression and modulation of cognitive
performances were also evaluated.
MATERIALS AND METHODS
ANIMALS
Procedures involving animals and their care were approved by
the institutional Ethics Committee (CeSI protocol #: AD-301)
conducted in conformity with the institutional guidelines that
are in compliance with national (D.L. n. 116, G.U., suppl. 40,
18 February, 1992) and international laws and policies. All
efforts were made to reduce animal number and to minimize
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their suffering. Triple-transgenic mice, the 3xTg-AD, overex-
pressing mutant APP (APPSwe), PS1 (PS1M146V), and hyper-
phosphorylated tau (tauP301L), were originally obtained by Oddo
et al. (2003), by coinjecting two independent human trans-
genes, APPSwe and tauP301L, in single-cell embryos that are
harvested from mutant homozygous PS1M146V knock-in mice
(PS1-KI). PS1-KI mice were originally generated on a hybrid
129/C57BL6 background (Guo et al., 1999). Hemizygous F1 mice
were crossed to obtain mice homozygous for all three transgenes.
These mice have been characterized by Oddo et al. (2003) and
generously provided by Frank LaFerla. Thus, non-Tg mice of the
same mixed 129/C57BL6 background have been used as (WT)
controls.
Three months of age (m.o.a.) female 3xTg-AD and WT mice
(n= 6 for group) together with 12 m.o.a. female 3xTg-AD and
WT mice (n= 6 for group) were enrolled for the study. As previ-
ously indicated (Giménez-Llort et al., 2007; Sterniczuk et al., 2010),
we have not observed major motor or visuomotor coordination
deficits. We also did not observe major motivational problems.
BEHAVIORAL TASK – MORRIS WATER MAZE
To perform the Morris Water Maze (MWM) (Morris, 1984), we
employed a circular pool (1.3 m diameter) filled with water. The
maze was placed in a room containing several intra and extra-maze
visual landmarks. The test was performed in accordance with what
described for AD mouse models (Puzzo et al., 2014). Mice were
trained to swim in the pool until they climbed on a white escape
platform (10 cm in diameter), located in the middle of one of the
four quadrants positioned at a depth of 2 cm below water surface.
Before the beginning of the first training session, mice were placed
on the escape platform for 10 s in order to allow an initial orien-
tation in the pool. If a mouse did not find the platform within
90 s, the animal was guided to it by the experimenter and allowed
to remain there for an additional 10 s. Mice were given four trials
per day separated by an inter-trial interval of 20 min for four con-
secutive days. Analysis of the learning curve in a subset of mice
(3 m.o.a WT= 3n; 3 m.o.a. 3xTg-AD= 4n; 12 m.o.a. WT= 5n;
12 m.o.a; 12 m.o.a. 3xTg-AD= 4n), showed that all the animals
learned the task equally well within the fourth day of learning.
Spatial memory retention was evaluated 1.5 and 24 h after the end
of the last training trial. Both probe trials consisted of a 60 s free
swim in the pool where the platform has been removed. Parame-
ters employed to evaluate memory skills were time to reach the
platform location (latency), number of crosses over the platform
location (crosses), and time spent in target (T. Target) and opposite
(T. Opposite) quadrants. All the enrolled animals were tested and
completed the evaluation. No differences in navigation speed were
observed in old mice when comparing the two strains. Analysis of
swim speed [with the SMART 2.5.21 program (Panlab, Barcelona,
Spain] showed statistically non-significant differences among the
two study groups as mean speed (cm/s)± SEM was 24.99± 1.78
in 12.m.o.a WT mice and 27.45± 3.78 in age-matched 3xTg-AD
mice (p= 0.058). Interestingly (possibly indicating a compen-
satory mechanism taking place in pre-symptomatic AD mice),
young (3 m.o.a) 3xTg-AD mice were significantly faster with
34.00± 0.53 compared to age-matched WT mice (25.98± 1.66;
P = 0.01).
QUANTITATIVE REAL-TIME PCR ANALYSIS
After completion of behavioral tasks, animal were sacrificed by
carbon dioxide inhalation, hippocampi dissected, kept in RNAlater
RNA Stabilization Reagent (Qiagen, Hilden, Germany), and stored
at −80°C. For RNA analysis, hippocampi were homogenized by
a hand glass potter and total RNA extracted using the RNeasy
Microarray Tissue Mini Kit (Qiagen, Hilden, Germany) according
to the manufacturer protocol. The purity and quantity of RNA
were assessed by Agilent 8453 Spectrophotometer (Agilent, Santa
Clara, CA, USA). One microgram of total RNA was used for cDNA
synthesis performed in a 20µl reaction through the high-capacity
cDNA reverse transcription kit (Applied Biosystems, Paisley, UK).
Reaction conditions were as follows: 37°C for 60 min, 95°C for
5 min, and cool at 4°C. Quantitative real-time PCR analysis (qRT-
PCR) was carried out on the ABI 7900HT Sequencing Detection
System (Applied Biosystems, Paisley, UK). Amplification reaction
was performed in a total volume of 30µl containing 1× TaqMan
Universal PCR Master mix, no AmpErase UNG (Applied Biosys-
tems, Paisley, UK), and 1.5µl of target cDNA along with the Prime
Time Mini qPCR Assay (Integrated DNA Technologies, Coralville,
IA, USA). Mouse gene-specific primer and fluorescent probe
sets were: primer Fw: 5′-CTTTGTCAAGCTCATTTCCTGG-
3′, primer Rev: 5′-TCTTGCTCAGTGTCCTTGC-3′, probe 5′-
CACCCTGTTGCTGTAGCCGTATTCA-3′, for glyceraldehyde 3-
phosphate dehydrogenase (GAPDH); primer Fw: 5′-ACCCTCCAT
GTGATCGAAATG-3′, primer Rev: 5′-GGTTCTATTCTGGACG
CTTGAG-3′, probe: 5′-ATAAATTTGTCCCCGCAGCCACG-3′,
for GluA1; primer Fw: 5′-AAAGAATACCCTGGAGCACAC-3′,
primer Rev: 5′-CCAAACAATCTCCTGCATTTCC-3′, probe: 5′-
ACTTCGGCCCTGACTTATGATGCTG-3′, for GluA2; primer Fw:
5′-AGTGGGAGAAGTTTGTGTACC-3′, Rev: 5′-TGATGCGTC
TGAATTCCTGG-3′, probe: 5′-ACAGAACGAGGGTTTTCCATC
CTGC-3′, for GluA3; primer Fw: 5′-TTCTACATTCTGGTTGG
CGG-3′, primer Rev: 5′-CCTGGCTTTGTTTCTTATGGC-3′,
probe: 5′-TCAGCTTCATTCTCTTCGCCTCTGC-3′, for GluA4.
Six biological replicates were performed for each study group for
a total of 24 mice. All the experiments were carried out in trip-
licates for each data point. The positive reaction was detected by
accumulation of fluorescent signals. Data analysis was performed
using the Ct value (threshold cycle) defined as the PCR cycle at
which the amplification curve intercepts the threshold fluores-
cence. Threshold fluorescence has been defined as the numerical
value that reflects a statistically significant point above the back-
ground signal (baseline). Using the 2−∆Ct method (Schmittgen
and Livak,2008), relative expression levels of GluA1–4 mRNA were
calculated for each sample after normalization against GAPDH,
the housekeeping gene.
GLuA2 Q/R EDITING
To assess GluA2 editing, we performed a sequencing analy-
sis in agreement with the method described by Barbon et al.
(2003). For each sample, PCR amplification of the GluA2 cDNA
region containing the editing Q/R site was carried out using
the primer pairs Fw: 5′-CGAGTGGCACACTGAGGAAT-3′ and
Rev: 5′-CTCTTTAGTGGAGCCAGAGTCTAA-3′, thereby gener-
ating a fragment of 325 bp in length. All amplicons were subse-
quently sequenced with forward and reverse primers. A Big Dye
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Terminator Kit (Applied Biosystems, Paisley, UK) was employed
to perform sequencing and samples then analyzed on an ABI
3130xl automatic sequencer (Applied Biosystems, Paisley, UK),
an analytical tool that has an accuracy of base calling of 98.5%.
STATISTICAL ANALYSIS
Statistical analysis of MWM and gene expression data was per-
formed by two-factor ANOVA followed by Fisher’s least significant
difference (LSD) post hoc test using Statistica 6.0 software (Statsoft,
Tulsa, OK, USA). Genotype and age were the independent factors.
Outliers were detected by Grubbs’ test. Significance of correla-
tions between MWM cognitive performances (latency and crosses)
and qRT-PCR expression levels of AMPAR subunits were assessed
by Spearman correlation analysis using MetaboAnalyst statistical
analysis module (Xia and Wishart, 2011). Data were derived from
each study group (i.e., 3 and 12 months old 3xTg-AD mice and
3 and 12 months old WT mice). p values <0.050 were considered
statistically significant. Correction for multiple comparisons was
performed using the false discovery rate (FDR) method. p values
<0.050 (FDR <0.100) were considered statistically significant.
RESULTS
EXPRESSION ANALYSIS OF GluA1–4 BY qRT-PCR
Hippocampal GluA1, GluA2, GluA3, and GluA4 transcriptional
levels in 3xTg-AD mice at 3 or 12 m.o.a. as well as in age-
matched WT animals were studied by qRT-PCR. Each gene level
was evaluated as 2−∆Ct, an index of gene expression that is nor-
malized to the GAPDH. This reference gene showed comparable
expression levels through the study groups (mean Ct ± 95% con-
fidence level= 17.6± 0.3 and 17.7± 0.2 for 3 and 12 m.o.a. for
WT mice, and 17.7± 0.2 and 17.5± 0.3 for 3 and 12 m.o.a. for
3xTg-AD mice; Table S1). For GluA1, expression (mean± S.E.M.)
values were 0.068± 0.005 in 3xTg-AD mice at 3 m.o.a. and
0.055± 0.009 in age-matched WT mice while in 3xTg-AD mice
at 12 m.o.a values were 0.049± 0.007 and 0.046± 0.002 in age-
matched WT animals. For GluA2, we found 0.030± 0.002 in
young 3xTg-AD mice and 0.022± 0.005 in age-matched WT
mice or 0.019± 0.003 in old 3xTg-AD animals and 0.037± 0.009
in age-matched WT animals. For GluA3, expression levels were
0.011± 0.001 in young 3xTg-AD mice and 0.006± 0.001 in age-
matched WT mice or 0.006± 0.001 in old 3xTg-AD animals and
0.013± 0.002 in age-matched WT mice. For GluA4, values were
0.003± 0.0005 in young 3xTg-AD mice and 0.002± 0.0003 in age-
matched WT mice or 0.002± 0.0001 in old 3xTg-AD animals and
0.002± 0.0002 in age-matched WT animals.
We then sorted effects of aging and genotype on AMPAR
subunit expression levels. For clarity, results are presented as
follows.
Effect of aging
GluA1–4 genes expression varied upon aging in WT and 3xTg-
AD mice. In WT mice, aging promoted a significant up-regulation
of GluA3 gene expression (p= 0.004). A similar trend, that, how-
ever, did not reach statistical significance, was observed for GluA2
(p= 0.073). No effects were observed for the other subunits
(Figure 1A). In 3xTg-AD mice, aging promoted a statistically sig-
nificant reduction of all the AMPAR subunits (GluA1, p= 0.045;
GluA3, p= 0.047; GluA4, p= 0.011; Figure 1B) with the exception
of GluA2 that remained stable (Table S2).
Effect of genotype
Comparison between young 3xTg-AD vs. age-matched WT mice
revealed that Tg-AD animals showed a significant up-regulation
of GluA3 (p= 0.039) and GluA4 (p= 0.007) whereas no changes
were detected for GluA1 and GluA2 (Figure 1C).
Comparison between old 3xTg-AD mice vs. age-matched WT
animals showed, in the AD mice, a significant down-regulation of
GluA2 (p= 0.038) and GluA3 (p= 0.005) while expression levels
of GluA1 and GluA4 were unchanged (Figure 1D; Table S2).
EDITING
The editing process of GluA2 pre-mRNAs results in the substitu-
tion of a codon for glutamine (CAG) with a codon for arginine
(CGG) at the so-called Q/R site. This post-transcriptional change
of GluA2 transcripts confers to AMPARs impermeability to Ca2+
and other divalents (Kawahara et al., 2004). Incomplete editing
has been shown to occur in neuropathological conditions and we
have therefore evaluated the process in our preclinical AD model.
To assess Q/R site editing of GluA2 pre-mRNAs, each sam-
ple was sequenced using forward and reverse primers. Editing
remained extremely efficient in all animals throughout develop-
ment and aging. The Adenine to Guanine substitution in the Q/R
site occurred in all the analyzed sequences (Figure 2). The forward
and reverse sequences provided equivalent results.
3xTG-AD MICE SHOW COGNITIVE DEFICITS AS ASSESSED BY MWM
TEST
Spatial learning and memory were investigated with the MWM
test, a behavioral test that evaluates hippocampal-dependent
memory, one of the first cognitive functions that is lost in the
course of AD (Morris, 1984; Puzzo et al., 2014). Young and old
animals (at 3 and 12 m.o.a.) underwent a 4 days training period.
1.5 and 24 h after the last training trials, mice were tested with
probe trials in order to evaluate short- and long-term memory
performances, respectively. While all the 3xTg-AD mice eventually
learned as well as the WT animals at the end of the fourth day of
training, clear differences were found especially in old 3xTg-AD
animals that showed impairments in the first 3 days of training
(Figure S1). When compared to age-matched WT mice, old Tg-
AD animals showed statistically significant differences in learning
performances as expressed by latencies in the first and second day
of training (Figure S1B; p= 0.012 and p= 0.032, respectively).
As expected (Oddo et al., 2003), old 3xTg-AD mice also showed
deficits in long-term memory (24 h probe test; Figures 3E,F) as
indicated by the statistically significant reduction in the number
of crosses made over the site where the platform used to be located
in the training phase (p= 0.023) and also exhibited a trend toward
increased time spent in search of the platform (p= 0.092). When
comparing old 3xtg-AD mice with age-matched WT animals,
analysis of additional parameters showed no significant differences
in T. Target scores (Figure 3G), while a trend toward significance
was found in term of decreased T. Opposite scores of old 3xTg-
AD mice (Figure 3H). A single item, the T. Opposite result is not
indicative of a better performance as, when considered in conjunc-
tion with latencies and number of crosses, it simply indicates that
Frontiers in Aging Neuroscience www.frontiersin.org August 2014 | Volume 6 | Article 200 | 4
Cantanelli et al. GluA expression in 3xTg-AD
FIGURE 1 | Quantitative real-time PCR analysis of GluA1–4 genes is
shown. Graph bars depict mean expression levels of GluA1–4 relative to the
internal reference. (A) Comparison between 12 m.o.a (old) vs. 3 m.o.a
(young) animals WT mice showed an increase in GluA3 expression level
(*p=0.004). A trend toward increased levels of GluA2 expression was also
found (~p=0.073). (B) Comparison between old vs. young mice 3xTg-AD
animals showed decreases in GluA1, 3, and 4 expression levels (*p=0.045;
*p=0.047; *p=0.011, respectively). (C) In AD mice, comparison between
3xTg-AD mice vs. WT mice at 3 m.o.a. showed increases in GluA3
(*p=0.039) and GluA4 (*p=0.030) expression levels. (D) Comparison
between 3xTg-AD mice vs. age-matched WT mice showed a decrease in
GluA2 (*p=0.038) and GluA3 (*p=0.005) expression levels in the 3xTg-AD
animals. Data are expressed as mean values±SEM obtained from six mice
in each study group. P value is the result of two-factor ANOVA and Fisher’s
least significant difference (LSD) post hoc test (*p< 0.05; ~trend
0.05<p<0.1).
FIGURE 2 | Representative electropherogram of GluA2 Q/R editing-site sequence analysis. All animals, 3xTg-AD and WT, showed full editing with the
Adenine to Guanine (A>G) substitution in the GluA2 Q/R editing site (arrow) indicated by the presence of a black peak (G) and the absence of a green peak (A).
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FIGURE 3 | 3xTg-AD mice show cognitive deficits assessed by MWM
test. MWM performances of 3xTg-AD mice at 3 and 12 m.o.a. (n=6 for
group) and age-matched control mice (WT) expressed as latency
(A,E), number of crosses (B,F), and time spent in target (C,G) and opposite
(D,H) quadrants, all tested 1.5 h and at 24 h after the last training session.
Compared to age-matched controls, long-term memory of old 3xTg-AD mice
was impaired as indicated by statistically significant reduction in number of
crosses (*p=0.022) and increase in time (latency; ~p=0.092) that animals
employed to reach the point where the platform used to be. Results are
expressed as mean values±SEM. P value is the result of two-factor ANOVA
and Fisher’s least significant difference (LSD) post hoc test (*p<0.05; ~trend
0.05<p<0.1).
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old 3xTg-AD mice show deficits in reaching the platform quadrant
and randomly navigate over out-of-target quadrants. No cognitive
deficits were observed in young 3xTg-AD mice when compared to
age-matched WT animals (Figures 3A–D; Table S3).
CORRELATION ANALYSIS BETWEEN mRNA GluA1–4 EXPRESSION
LEVELS AND MWM PERFORMANCES
In order to evaluate how AMPAR modulation can affect cognitive
performances in the two study groups, we performed a corre-
lation analysis between mRNA levels of each AMPAR subunit
and scores (crosses and latency) of MWM parameters obtained
in young and old mice. Young WT mice showed a negative
correlation between GluA2 expression levels and efficient long-
term memory performances as evaluated by assessing latency in
the 24 h probe test (Spearman coefficient=−0.841, p= 0.033,
FDR= 0.096; Figure 4; Table S4). Conversely, in young 3xTg-AD
mice, GluA2 expression levels positively correlated with impaired
short-term memory performances (as evaluated by assessing
latency in the 1.5 h probe test; Spearman coefficient= 1.000,
p= 0.003, FDR= 0.011; Figure 5; Table S5). Of note, we found that
Glua2-dependent effects were found lost in aged mice, similarly to
what found for the other subunits, as no significant correlations
were found between MWM performances and GluA2 levels in WT
and 3xTg-AD mice at 12 m.o.a (Tables S6 and S7).
DISCUSSION
Synaptic failure plays a critical role in the etiology of AD. A growing
body of evidence indicates that Aβoligomers, one of the most com-
mon hallmarks of AD, induce early morphofunctional and neu-
rotransmission changes that lead to synaptic depression (Lambert
et al., 1998; Hsia et al., 1999; Klein et al., 2001; Hardy and Selkoe,
2002; Klein, 2002; Kamenetz et al., 2003; Walsh and Selkoe, 2004).
Aβ oligomers have been indicated to act on AMPARs to affect
LTP (Parameshwaran et al., 2007; Yamin, 2009). Previous studies
have shown that direct application of Aβ oligomers on hippocam-
pal slices promote a reduction in amplitude and frequency of
miniature excitatory post-synaptic current (mEPSC) in addition
to trigger decreases in AMPAR open probability (Parameshwaran
et al., 2007; Yamin, 2009). Oligomeric Aβ also promotes, caspase 3-
dependent, removal of synaptic AMPARs, a process that, by itself,
can induce spine loss and enhances LTD (Hsieh et al., 2006; Li
et al., 2009; D’Amelio et al., 2011; Hu et al., 2012).
With this rationale, we have investigated whether changes of
AMPAR subunit transcriptional levels may occur in 3xTg-AD
mice, a preclinical model that reproduces the main pathological
features of the AD brain.
In the hippocampus, a strategic and AD-targeted region, 3xTg-
AD mice showed more prominent expression of GluA1 and GluA2
mRNAs while expression of GluA3 was lower and minimal levels
of GluA4 were found. The GluA subunit presence is in agreement
with prior studies that described a largely bimodal distribution of
AMPARs, a process that is physiologically occurring in the hip-
pocampus of non-transgenic mice (Craig et al., 1993; Wenthold
et al., 1996; Black, 2005; Bassani et al., 2013).
According to that systematization, the first AMPAR popu-
lation encompasses channels made of GluA1–GluA2 subunits
while the second population is represented by receptors com-
posed of GluA2–GluA3 subunits. Largely less represented are
GluA1–GluA3 AMPARs or homomeric GluA1 receptors.
Compared to age-matched WT mice, old 3xTg-AD mice
showed a GluA2 down-regulation (Figure 1D). Assessment of age-
dependent changes in transcriptional levels for GluA1–4 indicated
that, through development, the two strains may have implemented
different strategies to maintain a prevalence of CaI-AMPARs.
In WT mice, we observed an aging-dependent increase in
GluA2 expression whereas, in 3xTg-AD animals, aging promoted
down-regulation of all the GluA subunits with the exception of
GluA2, the only subunit that remained unchanged (Figures 1A,B).
FIGURE 4 | Correlation analysis between GluA1–4 expression levels and
MWM cognitive performances of WT mice is shown. (A) Heatmap shows
Spearman’s correlations between GluA1–4 expression levels (2−∆Ct) and
MWM parameters (latency and crosses) in young WT mice. Direct and
inverse correlations are shown in red and green, respectively. (B) WT mice
showed an inverse correlation between GluA2 and MWM latency at 24 h.
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FIGURE 5 | Correlation analysis between GluA1–4 expression levels and
MWM cognitive performances of 3xTg-AD mice is shown. (A) Heatmap
shows Spearman’s correlations between GluA1–4 expression levels (2−∆Ct)
and MWM parameters (latency and crosses) in young 3xTg-AD mice. Direct
and inverse correlations are shown in red and green, respectively. (B) 3xTg-AD
mice showed a direct correlation between GluA2 and MWM latency at 1.5 h.
In the 3xTg-AD mice, the emerging picture is that 3xTg-AD
mice exhibited an overall decrease of AMPARs (Figure 1B), but
at least preserved Ca2+-impermeability of their AMPARs. The
phenomenon can be considered as a potential defensive strat-
egy against CaP-AMPAR-driven excitotoxicity, but leaves open
the possibility of defective AMPAR-dependent modulation of
hippocampal synchronization.
The reduced number of AMPARs in old 3xTg-AD mice can
have important consequences and be coupled with plasticity
deficits as reduction in the number of these receptors can impair
the desilencing of silent synapses (Hanse et al., 2013), a cru-
cial mechanism that regulates LTP and LTD (Isaac et al., 1995).
According to the model (Isaac et al., 1995), silent synapses show
relative abundance of NMDARs but lack a significant amount of
AMPARs. In this context, AMPARs mediate the depolarization
that is critically needed to remove the voltage-dependent Mg2+
blockade of NMDARs, a key step required to achieve efficient
glutamatergic neurotransmission (Isaac et al., 1995). The age-
related modification in GluA mRNA levels that we have observed
matched the cognitive deficits found in our old 3xTg-AD mice
(Figures 3C,D).
Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tor alterations also occur early in 3xTg-AD mice. Indeed, in
3xTg-AD mice at 3 m.o.a., we found up-regulation of GluA3
and GluA4 expression while GluA1 and GluA2 remained sta-
ble (Figure 1C), thereby suggesting a functional switch toward
different heterotetrameric AMPAR configurations.
Changes in GluA3 levels are intriguing. The subunit is increased
in young AD mice but then decreases with aging in 3xTg-
AD mice at 12 m.o.a. (Figure 1B). WT animals showed the
opposite phenomenon with the development of age-dependent
GluA3 increases (Figure 1A). A functional interpretation of the
phenomenon should take into account that increased levels of
GluA3 [along with transmembrane AMPAR regulatory proteins
(TARPs)] lead to potentiation of synaptic transmission and LTD
facilitation (Blair et al., 2013). Thus, GluA3 rises observed in young
3xTg-AD mice could represent an attempt to compensate defective
glutamatergic transmission.
As for GluA4, although the subunit expression appears to
be minimal, levels were found nevertheless increased in young
3xTg-AD mice. The phenomenon, again, could be read as com-
pensatory as the subunit is critical to reduce AMPAR desensi-
tization time (Geiger et al., 1995; Black, 2005), and therefore,
increased GluA4 levels may lead to enhanced glutamatergic trans-
mission. No changes in young 3xTg-AD mice appeared to occur
when considering the ratio between CaI- and CaP-AMPARs as
expression levels of GluA2 were found to be not significantly
changed.
Correlation analysis between GluA2 transcription levels and
cognitive performances as assessed with MWM tests highlighted
intra-individuals differences that occurred with opposite outputs
in young mice of the two strains, thereby leading to intriguing
inferences on the functional role played by the subunit.
In young WT mice, high levels of GluA2 expression were asso-
ciated with better long-term memory performances (Figure 4).
One can speculate that this cognitive improvement is related to
the known capability of GluA2 to increase spine size and density
as well as to promote higher receptor stability at post-synaptic sites
and induce LTP (Passafaro et al., 2003; Plant et al., 2006; Ripley
et al., 2011; Hanse et al., 2013).
Interestingly, compared to WT animals, AMPAR/behavior cor-
relations occurring in young 3xTg-AD mice were found to go in
the opposite direction. The Tg-AD mice that showed higher lev-
els of GluA2 (and therefore increased number of CaI AMPARs
and lower of CaP AMPARs) were also the one exhibiting more
impaired short-term memory performances (Figure 5B). The
possible interpretation of the phenomenon is complex and should
take into account expression levels of CaP AMPARs in two
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critical hippocampal subpopulations: the glutamatergic pyramidal
neurons and the GABAergic interneurons.
In this context, one can speculate that, young 3xTg-AD mice
with lower levels of CaP AMPAR have less efficient memory per-
formances because of the lost positive effects of the receptors in
the modulation of AMPAR-dependent synaptic plasticity. This is a
crucial issue when the loss is occurring in pyramidal neurons and
especially in the context of AD-related cognitive deficits.
High number of these highly Ca2+-permeable AMPARs can
in fact compensate for Aβ-related functional impairment of
NMDARs, the other major route for glutamate-driven Ca2+ entry
(Muller et al., 1988; Watt et al., 2004). Indeed, several studies have
indicated defective NMDAR functioning as a critical factor in trig-
gering synaptic depression driven by Aβ (Kamenetz et al., 2003;
Snyder et al., 2005; Yamin, 2009). The phenomenon may be related
to Aβ binding to NMDARs, a mechanism that promotes altered
Ca2+ homeostasis (De Felice et al., 2007; Shankar et al., 2007)
or by the selective binding of Aβ oligomers to the NMDAR sub-
unit, GluN2B. In that respect, Aβ binding to GluN2B can favor
conformational changes that impair NMDAR-dependent signal
transduction (Kessels et al., 2013). Thus, these findings support
the hypothesis that 3xTg-AD mice may have defective NMDAR-
dependent glutamatergic transmission, an occurrence leading to
decreased Ca2+-dependent signaling and possibly compensated by
sustained influx of the cation through GluA2-lacking AMPARs.
On the other hand, lack of CaP AMPARs may lead to decreased
functioning of GABAergic interneurons, an inhibitory population
that is known to possess high levels of these receptors. In that
context, an AMPAR-dependent decreased activity of GABAergic
interneurons can result in an out-of-synch hippocampus that fur-
ther promotes network instability and cognitive dysfunction as
well as a potentially excitotoxic overdrive.
This is particularly relevant when considering that, in preclin-
ical models of AD, including the 3xTg-AD mice, hippocampal
hyperactivation occurs before the appearance of Aβ plaque depo-
sition (Busche et al., 2012; Davis et al., 2014), a phenomenon also
described in AD patients (Bakker et al., 2012; Vossel et al., 2013).
In short, in 3xTg-AD mice that were poorly performing, a
reduction in CaP AMPAR expression in GABAergic neurons may
have brought to less efficient synchronization of hippocampal net-
works and led to cognitive deficits. On the same token, a decrease
in the number of these receptors in pyramidal neurons could have
at least promoted neuroprotection by reducing a major route for
excitotoxicity.
Interestingly, the GluA-2/behavioral correlations observed in
the two strains in young mice appear to be lost with aging of the
animals (Tables S6 and S7). A possible speculation relies on the fact
that aging induces a plethora of effects that could diminish and/or
overpower the weight of GluA1–4 changes in the modulation of
memory performances.
In our study, we did not explore potential effects of the MWM
training and tests in the modulation of GluA1–4 mRNA levels. We
have not evaluated untrained Tg-AD or control mice, and there-
fore, we cannot exclude that some of the GluA changes were in part
dependent on MWM training. The issue warrants further studies.
Our results do not support the hypothesis that, like in other
neurological conditions, the pro-AD background of our Tg-AD
mice can trigger an age-dependent increase in the number of CaP-
AMPARs. In 3xTg-AD mice, we did not found age-dependent
changes in GluA2 levels or in the subunit editing. This finding
is not in line with a recent study that showed a slight reduction
in editing efficiency in the hippocampus of AD patients (Gaisler-
Salomon et al., 2014). The discrepancy is likely explained by the
obvious differences between preclinical AD models and the AD
brain.
Of note, an additional point that is emerging is that, although
3xTg-AD mice eventually did learn the MWM task as control
animals, the learning curve was slower and they showed impair-
ments in intermediate time points of the training. This phe-
nomenon suggests that our AD mice may have implemented
different strategies to successfully accomplish the task or, per-
haps, exhibited different responses to neuroendocrine modulators
that are known to affect AMPAR trafficking as well as plas-
ticity in behavioral tests like the MWM (Oitzl and de Kloet,
1992; Conboy and Sandi, 2010). For instance, behavioral tests set
in motion stress- and glucocorticoid-dependent responses that
induce a facilitation of learning and memory formation through
increased GluA2 trafficking (Sandi, 1998; Conboy and Sandi,
2010).
In addition, it is intriguing to speculate that the learning modal-
ity exhibited by the 3xTg-AD mice may also represent an indirect
index of the status of the animal cognitive reserve. The fact that
old 3xTg-AD mice eventually showed no learning deficits at the
fourth day of training leads to infer a more exploited use of this
resource in the animals.
In summary, present findings lend support to the idea that,
upon disease progression, critical modifications of glutamatergic
transmission may occur in the AD brain. In that context, and
always keeping in mind the limitations of preclinical AD models,
our study identifies a distinct AMPAR-mediated component.
In the framework of AD-related glutamatergic deficits, fur-
ther investigation is warrant to identify better and more selective
pharmacological tools that can help in modulating the delicate
ratio between AMPAR- and NMDAR-dependent transmission.
For instance, in this regard, it could be interesting to explore the
efficacy of ampakines as these AMPAR modulators can enhance
synaptic plasticity and improve cognitive performances (Stäubli
et al., 1994; Ingvar et al., 1997).
Furthermore, at this point, it is not possible to pin down
whether AMPAR subunit expression was able to modify behavioral
response by acting on many or just one of the critical hippocam-
pal subregions (CA1, CA3, and dentate gyrus). However, in this
first attempt to correlate hippocampal GluA levels with behav-
ior, we decided to have a more robust output by using the whole
hippocampus. Future studies are needed to explore correlations
between behavior and AMPAR distribution in key hippocampal
subregions.
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